Latest Weight Loss Surgery News
Recent Posts
Search Posts
Archives
March 2022February 2021
November 2020
October 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
October 2014
July 2014
June 2014
May 2014
March 2014
February 2014
January 2014
December 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
Categories
General
Joint Statement States that Weight-Loss Surgery be Used as Treatment for Diabetes in Obese Patients
posted by Admin User at 2016-06-14 11:35:00
The statement has been endorsed by the American Diabetes Association (ADA), the International Diabetes Federation and 43 other health groups.
The guidelines are based on “a large body of evidence including 11 randomized clinical trials showing that in most cases surgery can either reduce blood sugar levels below diabetic thresholds ("diabetes remission") or maintain adequate glycemic control despite major reduction in medication usage.”
The new global guidelines were developed at the 2nd Diabetes Surgery Summit (DSS-II), an international consensus conference, as a collaboration between 48 international clinicians/scholars (75% nonsurgeons) and world-leading diabetes organizations. The guidelines are aimed towards policymakers and clinicians, informing them of the benefits and limitations of weight-loss surgery for type II diabetes.
The summit published its results in the statement: “Given its role in metabolic regulation, the gastrointestinal tract constitutes a meaningful target to manage T2D. Numerous randomized clinical trials, albeit mostly short/midterm, demonstrate that metabolic surgery achieves excellent glycemic control and reduces cardiovascular risk factors. On the basis of such evidence, metabolic surgery should be recommended to treat T2D in patients with class III obesity (BMI ≥40 kg/m2) and in those with class II obesity (BMI 35.0–39.9 kg/m2) when hyperglycemia is inadequately controlled by lifestyle and optimal medical therapy. Surgery should also be considered for patients with T2D and BMI 30.0–34.9 kg/m2 if hyperglycemia is inadequately controlled despite optimal treatment with either oral or injectable medications. These BMI thresholds should be reduced by 2.5 kg/m2 for Asian patients.”
These guidelines mark the first time weight-loss surgery is recommended as treatment for diabetics, rather than a treatment targeted towards obese patients only. If you suffer from diabetes, weight-loss surgery could be just the treatment needed- talk to your doctor today!
